LHC Group (LHCG) has a P/E ratio of 86.2, above the Healthcare sector average of 25.72.
Get informed when a big investor buys or sells
+ Follow86.20
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
LHC Group's p/e ratio stands at 86.2. That is above the Healthcare sector average of 25.72. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
LHC Group sits higher the Healthcare benchmark (25.72) with a P/E ratio of 86.2. That is roughly 235.2% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether 86.2 is attractive depends on LHC Group's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how LHC Group's P/E ratio evolved across reporting periods, while the comparison chart places LHCG next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, P/E ratio is commonly used to spot outliers. LHC Group's reading of 86.2 (sector avg 25.72) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.